MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Integra Lifesciences Holdings Corp Company Profile (NASDAQ:IART)

Consensus Ratings for Integra Lifesciences Holdings Corp (NASDAQ:IART) (?)
Ratings Breakdown: 2 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $78.13 (0.16% upside)

Analysts' Ratings History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2016Piper JaffrayReiterated RatingOverweight$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016BarclaysBoost Price TargetEqual Weight$74.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Lake Street CapitalBoost Price TargetHold$57.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Citigroup Inc.Initiated CoverageBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015Bank of AmericaUpgradeNeutral -> Buy$72.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015JPMorgan Chase & Co.UpgradeNeutral -> Overweight$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Raymond JamesUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015RBC CapitalBoost Price TargetSector Perform$62.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Wells FargoUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015ArgusBoost Price TargetBuy$61.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.75$0.79$239.91 million$244.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.64$0.68$229.32 million$231.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$0.77$0.85ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012$0.69$0.74ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.60$0.71ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012$0.55$0.72ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2011$0.77$0.77ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.61$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.66$0.66ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$0.73$0.80ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Integra Lifesciences Holdings Corp (NASDAQ:IART)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$0.72$0.85$0.78
Q2 20164$0.76$0.85$0.80
Q3 20164$0.87$0.90$0.89
Q4 20165$0.97$1.06$1.02
Q1 20172$0.86$0.86$0.86
Q2 20172$0.83$0.89$0.86
Q3 20172$0.84$1.01$0.93
Q4 20172$0.96$1.16$1.06
(Data provided by Zacks Investment Research)
Dividend History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Integra Lifesciences Holdings Corp (NASDAQ:IART)
DateHeadline
06/28/16 09:28 AMIntegra LifeSciences Holdings Larger Than S&P 500 Component Chesapeake Energy
06/16/16 02:09 AMIntegra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 - 17, 2016 in Lisbon, Portugal - [at noodls] - June 16, 2016 PLAINSBORO, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it is holding its first International Symposium on Tissue ...
06/12/16 07:18 AMIntegra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 09 Session
06/10/16 04:41 PMIntroducing Dentsply Sirona, a Leading Dental Products Manufacturer
06/05/16 04:30 PMIntegra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 02 Session
05/31/16 04:44 PMShares Touching a Recent High: Integra LifeSciences Holdings Corporation (NASDAQ:IART) - The EPS growth for the past five (5) years shows a value of 19.70%, whilst the EPS value for the next five (5) years shows a figure of 16.82%. Company shares were Reiterated by Canaccord Genuity on April 27, 2016 to "Buy", Firm has raised the Price Target ...
05/30/16 11:52 AMAfter Last Week What Do Analysts Think Of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Share Trading News - After Last Week What Do Analysts Think Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)Share Trading News11/11/2013 – Integra LifeSciences Holdings Corporation was upgraded to “equal weight” by analysts at Morgan Stanley. They now have a USD 40 price target on the stock. The share price of Integra LifeSciences Holdings Corporation (NASDAQ:IART) was up ...and more »
05/29/16 11:04 AMIntegra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased By 9.86% - HNN - Integra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased By 9.86%HNNThe stock of Integra Lifesciences Holdings Corporation (NASDAQ:IART) registered an increase of 9.86% in short interest. IART's total short interest was 3.17M shares in May as published by FINRA. Its up 9.86% from 2.88M shares, reported previously.Integra LifeSciences Holdings Corporation (NASDAQ:IART) Quarterly EPS From Continuing Operations Stands At $0.32Enterprise LeaderMitsubishi Ufj Securities Holdings Ltd. adds Integra Lifesciences Holdings Corp (IART) to its portfolioMarket DigestIntegra LifeSciences Holdings Corporation (NASDAQ:IART) Closes At $73.11Vanguard TribuneThe News Journal -Risers & Fallers -CCH Daily Newsall 10 news articles »
05/28/16 08:40 AM8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls -
05/26/16 03:16 PMINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/26/16 10:23 AMIntegra LifeSciences Holdings Corp (IART) Hits New 52-week High During May 23 Session - Equities.com - Integra LifeSciences Holdings Corp (IART) Hits New 52-week High During May 23 SessionEquities.comIntegra LifeSciences Holdings Corp (IART) hit a new 52-week high yesterday, reaching a peak of $74.49 after opening at $72.76 and closing at $71.86 for a move of -0.8%. Hitting a new 52-week high is a notable milestone for any company, and it can mean ...and more »
05/25/16 03:26 PMIntegra LifeSciences to Present at the Jefferies 2016 Healthcare Conference in June 2016 - [at noodls] - May 25, 2016 PLAINSBORO, N.J., May 25, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in June: At 8:30AM ...
05/23/16 07:36 AMIntegra LifeSciences launches Integra® Fin-Lock™ Glenoid for the Titan™ Modular Shoulder System - [at noodls] - May 23, 2016 PLAINSBORO, N.J., May 23, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra® ...
05/11/16 07:30 AMIntegra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release - [GlobeNewswire] - PLAINSBORO, N.J., May 11, 2016-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, today announced that the Company has received approval from the U.S. Food and Drug ...
05/03/16 03:20 PMIntegra LifeSciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Healthcare Conference in May 2016 - [at noodls] - May 3, 2016 PLAINSBORO, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in May: At 1:00PM ...
05/03/16 12:04 PMINTEGRA LIFESCIENCES HOLDINGS CORP Financials -
05/02/16 12:13 PMIntegra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/28/16 12:36 PMIntegra (IART) Beats on Q1 Earnings, Grows Organically -
04/27/16 03:57 PMEdited Transcript of IART earnings conference call or presentation 27-Apr-16 12:30pm GMT -
04/27/16 06:07 AMQ1 2016 Integra LifeSciences Holdings Corp Earnings Release - Before Market Open -
04/27/16 05:18 AMIntegra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch - [at noodls] - April 27, 2016 PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company ...
04/27/16 05:09 AMIntegra beats Street 1Q forecasts -
04/09/16 01:24 PMIntegra LifeSciences Holdings Corporation (NASDAQ:IART): Earnings In Focus - Investor Newswire - Integra LifeSciences Holdings Corporation (NASDAQ:IART): Earnings In FocusInvestor NewswireFollowing the recent poll, Integra LifeSciences Holdings Corporation (NASDAQ:IART) can post EPS of $0.84 in the upcoming results, which can be disclosed anytime around 2016-05-05. The earnings target released by Thomson Reuter's may vary from EPS ...and more »
04/09/16 01:24 PMEarnings View for Integra LifeSciences Holdings Corporation (NASDAQ:IART) - RiversideGazette.com - Earnings View for Integra LifeSciences Holdings Corporation (NASDAQ:IART)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $0.73 on shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released ...and more »
04/06/16 03:27 PMIntegra LifeSciences to Host Its First Quarter 2016 Earnings Results Conference Call on April 27, 2016 - [at noodls] - April 6, 2016 PLAINSBORO, N.J., April 06, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its first quarter 2016 financial results on Wednesday, April 27, ...
03/15/16 12:10 PMEarnings Quick Look: Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Business Standard Tribune - Earnings Quick Look: Integra LifeSciences Holdings Corporation (NASDAQ:IART)Business Standard TribuneWall Street sell-side analysts are projecting that Integra LifeSciences Holdings Corporation (NASDAQ:IART) will post earnings of $0.73 per share for the current quarter. This is the Zack's Research consensus number which might slightly vary from other ...and more »
03/10/16 07:30 AMIntegra LifeSciences Awarded $10.3 Million Department of Defense Contract - [GlobeNewswire] - PLAINSBORO, N.J., March 10, 2016-- Integra LifeSciences Holding Corporation, a leading global medical technology company, today announced that through its partnership with Buffalo Supply, it has received ...
02/29/16 10:03 AMIntegra LifeSciences Holdings Corp. Earnings Analysis: 2015 By the Numbers -
02/26/16 05:29 PMINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 10-K, Annual Report -
02/26/16 08:29 AMIntegra LifeSciences Announces Service Alliance Agreement With PREZIO Health - GlobeNewswire (press release) - Integra LifeSciences Announces Service Alliance Agreement With PREZIO HealthGlobeNewswire (press release)PLAINSBORO, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (NASDAQ:IART) today announced its service alliance agreement with PREZIO Health, a leader in perioperative services, repair, maintenance and ...
02/26/16 08:29 AMEARNINGS SUMMARY: Details of Integra Lifesciences Holdings Corp Q4 Earnings Report - Below are the earnings highlights for Integra Lifesciences Holdings Corp (IART): -Earnings: $32.76 million in Q4 vs. $30.57 million in the same period last year. -EPS: $0.87 in Q4 vs. $0.92 in the same period last year. -Analysts projected $0.86 per share ...
02/26/16 07:30 AMIntegra LifeSciences to Present at the Canaccord 11th Annual Musculoskeletal Conference, Raymond James & Associates’ 37th Annual Institutional Investors Conference and the Barclays Global Healthcare Conference in March 2016 - [GlobeNewswire] - PLAINSBORO, N.J., Feb. 26, 2016-- Integra LifeSciences Holdings Corporation today announced that it will present at the following conference in March:. At 4:00PM ET on Tuesday, March 1, 2016, Mr. Mark ...
02/25/16 11:11 PMEdited Transcript of IART earnings conference call or presentation 25-Feb-16 9:30pm GMT -
02/25/16 03:34 PMIntegra beats Street 4Q forecasts -
02/25/16 03:30 PMIntegra LifeSciences Announces Service Alliance Agreement With PREZIO Health - [GlobeNewswire] - PLAINSBORO, N.J., Feb. 25, 2016-- Integra LifeSciences Holding Corporation today announced its service alliance agreement with PREZIO Health, a leader in perioperative services, repair, maintenance and ...
02/25/16 03:05 PM4:05 pm Integra beats by $0.01, reports revs in-line; guides FY16 EPS in-line, revs above consensus -
02/25/16 03:01 PMIntegra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance - [GlobeNewswire] - Fourth Quarter Revenues Increased 10.1% to $241.2 Million Fourth Quarter Adjusted EPS of $0.87; Reported EPS of $0.39 Full Year Organic Revenues Increased 6.7%. PLAINSBORO, N.J., Feb. 25, 2016-- Integra ...
02/25/16 06:07 AMQ4 2015 Integra LifeSciences Holdings Corp Earnings Release - After Market Close -
02/22/16 01:40 PMNew Price Targets On Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Risers & Fallers - New Price Targets On Integra LifeSciences Holdings Corporation (NASDAQ:IART)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART). The latest broker reports which are currently outstanding on Monday 22nd of February state 6 analysts have a ...Fisher Asset Management Increases Stake in Integra Lifesciences Holdings Corp (IART)Financial Market NewsThe Market View On Integra LifeSciences Holdings Corporation (NASDAQ:IART)'sVanguard TribuneEagle Asset Management Acquires 77964 Shares of Integra Lifesciences Holdings Corp (IART)Intercooler FinancialBusiness Standard Tribuneall 11 news articles »
02/20/16 01:04 PMBeta Top Ranked Stock: Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Stock Caller - Beta Top Ranked Stock: Integra LifeSciences Holdings Corporation (NASDAQ:IART)Stock CallerIntegra LifeSciences Holdings Corporation (NASDAQ:IART) has been handed a top rating by Beta Systems research. The rating takes into consideration a number of factors including potential future earnings growth, analyst sentiment as well as company ...
02/18/16 12:59 PMAnalysts Say Buy These Stocks: Integra LifeSciences Holdings Corporation (NASDAQ:IART), CalAmp Corp. (NASDAQ ... - RiversideGazette.com - Analysts Say Buy These Stocks: Integra LifeSciences Holdings Corporation (NASDAQ:IART), CalAmp Corp. (NASDAQ ...RiversideGazette.comWall Street analysts are maintaining Buy rating on Integra LifeSciences Holdings Corporation (NASDAQ:IART) company shares. The one year target on the name currently stands at $72.36. The stock recently touched $57.91 and has moved in the range of ...
02/15/16 11:55 AMIntegra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased By 13.81% - fdanewsalert.com - Integra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased By 13.81%fdanewsalert.comThe stock of Integra Lifesciences Holdings Corporation (NASDAQ:IART) registered an increase of 13.81% in short interest. IART's total short interest was 2.35M shares in February as published by FINRA. Its up 13.81% from 2.06 million shares, reported ...Recent Broker Updates On Integra LifeSciences Holdings Corporation (NASDAQ:IART)Risers & FallersIntegra Lifesciences Holdings Corp (NASDAQ:IART) Receives $72.33 Consensus Target Price from AnalystsFinancial Market NewsIntegra LifeSciences Holdings Corp (IART) Hits New 52-week Low During February 11 SessionEquities.comSonoran Weekly Review -The Vista Voice -Investor Newswireall 38 news articles »
02/12/16 12:30 PMIntegra LifeSciences Holdings Corp (IART) Hits New 52-week Low During February 11 Session - Equities.com - Integra LifeSciences Holdings Corp (IART) Hits New 52-week Low During February 11 SessionEquities.comIntegra LifeSciences Holdings Corp (IART) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $54.86, Integra LifeSciences Holdings Corp dropped to $54.75 for a new 52-week low. By the closing bell, ...TheStreet Downgrades Integra Lifesciences Holdings Corp (IART) to HoldThe Vista VoiceIntegra Lifesciences Holdings Corp (IART) Lowered to Hold at TheStreetFinancial Market NewsIntegra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased 9.42% After Market Sellingfdanewsalert.comVanguard Tribune -Intercooler Financial -Uptick Analystall 19 news articles »
02/10/16 12:25 PMIntegra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased 9.42% After Market Selling - fdanewsalert.com - Integra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased 9.42% After Market Sellingfdanewsalert.comThe stock of Integra Lifesciences Holdings Corporation (NASDAQ:IART) registered an increase of 9.42% in short interest. IART's total short interest was 2.06M shares in February as published by FINRA. Its up 9.42% from 1.89M shares, reported previously.
02/06/16 11:55 AMIntegra LifeSciences Holdings Corp (IART) Drops 5.25% on February 05 - Equities.com - Integra LifeSciences Holdings Corp (IART) Drops 5.25% on February 05Equities.comIntegra LifeSciences Holdings Corp (IART) was one of the Russell 2000's biggest losers for Friday February 05 as the stock slid 5.25% to $57.97, a loss of $-3.21 per share. Starting at an opening price of $60.94 a share, the stock traded between $57.63 ...EPS Forecast Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)Vanguard Tribuneall 2 news articles »
02/06/16 11:55 AMOversold Conditions For Integra LifeSciences Holdings (IART) - Nasdaq - Oversold Conditions For Integra LifeSciences Holdings (IART)NasdaqIn trading on Friday, shares of Integra LifeSciences Holdings Corp (Symbol: IART) entered into oversold territory, hitting an RSI reading of 28.1, after changing hands as low as $57.49 per share. By comparison, the current RSI reading of the S&P 500 ETF (.and more »
02/06/16 11:55 AMOversold Conditions For Integra LifeSciences Holdings (IART) - A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Integra LifeSciences Holdings Corp (Symbol: IART) entered into oversold territory, hitting an RSI reading of 28.1, after changing hands as low as $57.49 ...
02/03/16 06:27 PMLatest Analysts Reports On Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Risers & Fallers - Latest Analysts Reports On Integra LifeSciences Holdings Corporation (NASDAQ:IART)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART). The latest broker reports which have been released state 6 analysts have a rating of “buy”, 3 analysts “outperform ...On Analysts Radar: Integra LifeSciences Holdings Corporation (NASDAQ:IART)Equities FocusCaruso Richard E Bought More Integra Lifesciences Holdings Corp Sharesfdanewsalert.comall 3 news articles »
02/03/16 03:17 PMINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statement -
02/01/16 03:33 PMIntegra LifeSciences to Host Its Fourth Quarter 2015 Earnings Results Conference Call on February 25, 2016 - [at noodls] - February 1, 2016 PLAINSBORO, N.J., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its fourth quarter 2015 financial results on Thursday, February ...
About Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: IART
  • CUSIP: 45798520
Key Metrics:
  • Previous Close: $76.18
  • 50 Day Moving Average: $74.83
  • 200 Day Moving Average: $67.11
  • P/E Ratio: N/A
  • P/E Growth: 1.75
  • Market Cap: $2.90B
  • Current Quarter EPS Consensus Estimate: $3.44 EPS
Additional Links:
Integra Lifesciences Holdings Corp (NASDAQ:IART) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha